Intravenous Solutions Market
According to Intent Market Research, the Intravenous (IV) Solutions Market is expected to grow from USD 12.9 billion in 2024-e at a CAGR of 10.1% to touch USD 25.1 billion by 2030. The Intravenous (IV) Solutions Market is dominated by key players such as Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Hospira (Pfizer Inc.), Terumo Corporation and Otsuka Pharmaceutical Co., Ltd.